AJP - Endocrinology and Metabolism, Vol 248, Issue 6 741-E743, Copyright © 1985 by American Physiological Society
Corticotropin-releasing factor inhibits insulin release from perfused rat pancreas
J. H. Moltz and C. P. Fawcett
The ability of synthetic corticotropin-releasing factor (CRF) (rat) to
influence hormone release from the endocrine pancreas of rats has been
evaluated by means of perfusion in situ. Release of insulin and glucagon
into the perfusate was measured in the presence and absence of CRF (0.1, 1,
and 10 ng/ml) under conditions of normal and high glucose concentration
(5.5 and 11 mM). Under both conditions, CRF (0.1, 1, and 10 ng/ml) induced
a rapid, dose-dependent inhibition of insulin release followed by a
remarkable postinhibitory rebound when exposure to CRF was discontinued.
CRF had no significant effect on glucagon release when tested under these
conditions. These results are reminiscent of noradrenergic inhibition of
insulin release and together with evidence for the presence of CRF in the
pancreas suggest that this peptide could function as a neuromodulatory
transducer in addition to its role as a hypophysiotropic hormone perhaps
contributing to the coordination of the overall endocrine response to
stress.
